FDA APPROVES

"Cabometyx" cancer drug approved by FDA- Feb 2016. Previously tested in clinical trials at Mary Crowley.

~/media/Images/Homepage/FDARotator.ashxFDA APPROVES "Cabometyx" cancer drug approved by FDA- Feb 2016. Previously tested in clinical trials at Mary Crowley. --> false
~/media/Images/Homepage/WFAA.ashxABC News Story Mary Crowley patients says, "My immune system is in overdrive and knocking out my cancer". --> falsehttp://www.wfaa.com/news/health/grandmother-with-cancer-battles-the-odds-with-new-treatment/199867569Watch News Story
— Margaret Brown Patient
~/media/Images/Homepage/title-realsuccessstories.ashx
~/media/Images/Banners/Homepage/LectureSeriesRotator2016.ashxPHYSICIAN LECTURE SERIES Learn how to navigate patients through the genomic maze --> false/Home/Our Research/Lecture Series.aspxRead More
~/media/Images/Homepage/CBS11ImmunotherapyRotator.ashxIMMUNOTHERAPIES ADVANCE AT MARY CROWLEY"Doctors say it is a landmark victory that could change the way they treat many other types of cancers"...--> truehttp://www.youtube.com/embed/npVkOg-Ungw?autoplay=1See CBS News Story
~/media/Images/Homepage/Cancer-2016-Rotator.ashxHOW CANCER WILL AFFECT AMERICANS IN 2016Here's the good news about cancer in America: More people than ever are surviving it... --> false/Home/Media/News and Press Releases/NS - Washington Post Cancer in 2016.aspxSee News Story
— The Washington Post

Where Compassion Meets Science

Our mission is to expand treatment options for all cancer patients through investigational vaccine, gene and cellular therapies.

 


Follow Us

Find Us

Clinic:
7777 Forest Lane, Building C, Suite 707
Dallas, TX 75230
972-566-3000
Administrative Offices:
12222 Merit Drive
Suite 1500
Dallas, TX 75251
(214) 658-1999